Información:
Error:
ID
34209
Descripción
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases; ODM derived from: https://clinicaltrials.gov/show/NCT02419677
Link
https://clinicaltrials.gov/show/NCT02419677
Palabras clave
Versiones (1)
- 15/1/19 15/1/19 -
Titular de derechos de autor
see on clinicaltrials.gov
Subido en
15 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Colorectal Cancer NCT02419677
Eligibility Colorectal Cancer NCT02419677
- StudyEvent: Eligibility
Similar models
Eligibility Colorectal Cancer NCT02419677
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
patients with histologically confirmed adenocarcinoma
boolean
ID.2
Item
primary lesions (colorectal cancer) are resected
boolean
ID.3
Item
must have undergone prior complete resection of the primary tumor; liver metastases
boolean
ID.4
Item
must be resectable or accessible for radiofrequency ablation (five or less lung metastases measuring 5 cm or smaller).
boolean
ID.5
Item
serum bilirubin level of 2.0 mg/dl or less.
boolean
ID.6
Item
performance status of 0 or 1.
boolean
ID.7
Item
expected survival of 1 year or more.
boolean
ID.8
Item
informed consent from the patient.
boolean
ID.9
Item
with extrahepatic metastases
boolean
ID.10
Item
with other neoplastic disease that is measurable or being treated other than colorectal cancer.
boolean